Cargando…
Evaluating the seroprevalence of SARS-CoV-2 IgG in five different districts of Bangladesh. A seroepidemiological study
BACKGROUND: We aimed to measure the seroprevalences and levels of anti-SARS-CoV-2 IgG in children, unvaccinated and vaccinated adults in five districts of Bangladesh and thus, investigate the association of seroprevalence and anti-SARS-CoV-2 IgG level with respect to different attributes of study pa...
Autores principales: | Saba, Abdullah Al, Sayem, Mohammad, Rimon, Razoan Al, Sanyal, Mousumi, Chakraborty, Sajib, Rahman, Md Arifur, Rahman, Md Mizanur, Nabi, A.H.M. Nurun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110279/ https://www.ncbi.nlm.nih.gov/pubmed/37119719 http://dx.doi.org/10.1016/j.jiph.2023.04.013 |
Ejemplares similares
-
The polymorphic landscape analysis of GATA1 exons uncovered the genetic variants associated with higher thrombocytopenia in dengue patients
por: Al Rimon, Razoan, et al.
Publicado: (2022) -
Evaluation of D-loop hypervariable region I variations, haplogroups and copy number of mitochondrial DNA in Bangladeshi population with type 2 diabetes
por: Saha, Sajoy Kanti, et al.
Publicado: (2021) -
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest
por: Saba, Abdullah Al, et al.
Publicado: (2022) -
Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial
por: Chakraborty, Sajib, et al.
Publicado: (2020) -
An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest
por: Saba, Abdullah Al, et al.
Publicado: (2021)